<DOC>
	<DOC>NCT00847028</DOC>
	<brief_summary>This study investigates which concentration of glucose is most effective in reducing pain for venipuncture in the newborn.</brief_summary>
	<brief_title>Oral Glucose Solution as Pain Relief in Newborns: Results of a Clinical Trial</brief_title>
	<detailed_description>This double-blind clinical trial is conducted on a maternity and newborn (N*) ward. Each time, during at least one month, one of the four selected solutions (glucose 10%, 20%, 30% and placebo) will be administered orally, 2 minutes prior to the venipuncture. The pain from the skin puncture will be scored using a validated pain scale (the "Leuven" pain scale).</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Inclusion criteria Neonates were included if they had to undergo a venipuncture as part of routine medical care. Exclusion criteria Unstable neonates with respiratory support as well as neonates with a proven neurological abnormality were excluded. Newborns who had been administered sedatives, analgesics or naloxone during the past 48 hours were excluded along with premature infants younger than 32 weeks post menstrual age.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Newborn</keyword>
	<keyword>Pain</keyword>
	<keyword>glucose solution</keyword>
	<keyword>venipuncture</keyword>
	<keyword>non-pharmacologic pain relief.</keyword>
</DOC>